Wendy E. Smith

5.9k total citations · 1 hit paper
40 papers, 2.3k citations indexed

About

Wendy E. Smith is a scholar working on Clinical Biochemistry, Physiology and Genetics. According to data from OpenAlex, Wendy E. Smith has authored 40 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Clinical Biochemistry, 14 papers in Physiology and 13 papers in Genetics. Recurrent topics in Wendy E. Smith's work include Metabolism and Genetic Disorders (17 papers), Diet and metabolism studies (9 papers) and Neonatal Health and Biochemistry (7 papers). Wendy E. Smith is often cited by papers focused on Metabolism and Genetic Disorders (17 papers), Diet and metabolism studies (9 papers) and Neonatal Health and Biochemistry (7 papers). Wendy E. Smith collaborates with scholars based in United States, Canada and United Kingdom. Wendy E. Smith's co-authors include Cheleste M. Thorpe, David W. K. Acheson, Susan A. Berry, Jerry Vockley, Dianne M. Frazier, John J. Mitchell, Barbara K. Burton, Nancy Braverman, Hans C. Andersson and Barry H. Thompson and has published in prestigious journals such as Nature, SHILAP Revista de lepidopterología and The American Journal of Human Genetics.

In The Last Decade

Wendy E. Smith

39 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Phenylalanine hydroxylase deficiency: diagnosis and management guideline

2014 465 citations Jerry Vockley, Barbara K. Burton et al. Genetics in Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Wendy E. Smith United States	20	1.1k	806	710	473	415	40	2.3k
Stanley H. Korman Israel	30	1.2k 1.1×	828 1.0×	250 0.4×	186 0.4×	233 0.6×	94	2.3k
Kristin Eiklid Norway	24	521 0.5×	250 0.3×	144 0.2×	201 0.4×	47 0.1×	44	1.8k
Anthony H. Fensom United Kingdom	22	655 0.6×	153 0.2×	1.3k 1.8×	118 0.2×	173 0.4×	66	2.0k
S. Melançon Canada	16	751 0.7×	159 0.2×	178 0.3×	203 0.4×	99 0.2×	40	1.5k
Laurie D. Smith United States	19	467 0.4×	154 0.2×	186 0.3×	482 1.0×	50 0.1×	40	1.1k
Nataša Kopitar‐Jerala Slovenia	25	1.1k 1.0×	63 0.1×	364 0.5×	153 0.3×	278 0.7×	54	2.3k
Sophie Fillon United States	26	812 0.8×	44 0.1×	301 0.4×	136 0.3×	261 0.6×	41	2.0k
Hong‐Lin Su Taiwan	25	956 0.9×	88 0.1×	129 0.2×	99 0.2×	117 0.3×	58	2.0k
Kenichiro Yamada Japan	24	713 0.7×	131 0.2×	105 0.1×	258 0.5×	41 0.1×	94	2.0k
Anna Negroni Italy	27	992 0.9×	98 0.1×	146 0.2×	314 0.7×	27 0.1×	56	1.9k

Countries citing papers authored by Wendy E. Smith

Since Specialization

Citations

This map shows the geographic impact of Wendy E. Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wendy E. Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wendy E. Smith more than expected).

Fields of papers citing papers by Wendy E. Smith

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wendy E. Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wendy E. Smith. The network helps show where Wendy E. Smith may publish in the future.

Co-authorship network of co-authors of Wendy E. Smith

This figure shows the co-authorship network connecting the top 25 collaborators of Wendy E. Smith. A scholar is included among the top collaborators of Wendy E. Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wendy E. Smith. Wendy E. Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Miller, Marcus J., Adam D. Kennedy, Rebecca McClellan, et al.. (2025). The emerging role of metabolomics analysis in genetic and genomic testing: A points to consider statement of the American College of Medical Genetics and Genomics (ACMG). Genetics in Medicine. 27(10). 101493–101493.

Smith, Wendy E., Susan A. Berry, Christine Brown, et al.. (2024). Phenylalanine hydroxylase deficiency diagnosis and management: A 2023 evidence-based clinical guideline of the American College of Medical Genetics and Genomics (ACMG). Genetics in Medicine. 27(1). 101289–101289. 10 indexed citations

Díaz, George A., Andreas Schulze, Nicola Longo, et al.. (2019). Long-term safety and efficacy of glycerol phenylbutyrate for the management of urea cycle disorder patients. Molecular Genetics and Metabolism. 127(4). 336–345. 10 indexed citations

Berry, Susan A., Jerry Vockley, Alexander A. Vinks, et al.. (2018). Pharmacokinetics of glycerol phenylbutyrate in pediatric patients 2 months to 2 years of age with urea cycle disorders. Molecular Genetics and Metabolism. 125(3). 251–257. 8 indexed citations

Berry, Susan A., Nicola Longo, George A. Díaz, et al.. (2017). Safety and efficacy of glycerol phenylbutyrate for management of urea cycle disorders in patients aged 2 months to 2 years. Molecular Genetics and Metabolism. 122(3). 46–53. 14 indexed citations

Mokhtarani, Masoud, George A. Díaz, Uta Lichter‐Konecki, et al.. (2015). Urinary phenylacetylglutamine (U-PAGN) concentration as biomarker for adherence in patients with urea cycle disorders (UCD) treated with glycerol phenylbutyrate. SHILAP Revista de lepidopterología. 5. 12–14. 3 indexed citations

Berry, Susan A., Uta Lichter‐Konecki, George A. Díaz, et al.. (2014). Glycerol phenylbutyrate treatment in children with urea cycle disorders: Pooled analysis of short and long-term ammonia control and outcomes. Molecular Genetics and Metabolism. 112(1). 17–24. 27 indexed citations

Smith, Wendy E., George A. Díaz, Uta Lichter‐Konecki, et al.. (2013). Ammonia Control in Children Ages 2 Months through 5 Years with Urea Cycle Disorders: Comparison of Sodium Phenylbutyrate and Glycerol Phenylbutyrate. The Journal of Pediatrics. 162(6). 1228–1234.e1. 33 indexed citations

Barber, John, Jill A. Rosenfeld, Nicola Foulds, et al.. (2013). 8p23.1 duplication syndrome; common, confirmed, and novel features in six further patients. American Journal of Medical Genetics Part A. 161(3). 487–500. 33 indexed citations

10.

Siegel, Matthew & Wendy E. Smith. (2011). Psychiatric Features in Children with Genetic Syndromes: Toward Functional Phenotypes. Pediatric Clinics of North America. 58(4). 833–864. 15 indexed citations

11.

Rosenfeld, Jill A., Brad Angle, Valerie Banks, et al.. (2011). Distinctive phenotype in 9 patients with deletion of chromosome 1q24‐q25. American Journal of Medical Genetics Part A. 155(6). 1336–1351. 29 indexed citations

12.

Siegel, Matthew & Wendy E. Smith. (2010). Psychiatric Features in Children with Genetic Syndromes: Toward Functional Phenotypes. Child and Adolescent Psychiatric Clinics of North America. 19(2). 229–261. 18 indexed citations

13.

Moeschler, John B., Roberto Amato, Leah W. Burke, et al.. (2009). Improving genetic health care: A Northern New England pilot project addressing the genetic evaluation of the child with developmental delays or intellectual disability. American Journal of Medical Genetics Part C Seminars in Medical Genetics. 151C(3). 241–254. 13 indexed citations

14.

Smith, Wendy E., et al.. (2007). Sibling phenotype concordance in classical infantile Pompe disease. American Journal of Medical Genetics Part A. 143A(21). 2493–2501. 15 indexed citations

15.

Smith, Wendy E., Priya S. Kishnani, Brendan Lee, et al.. (2005). Urea Cycle Disorders: Clinical Presentation Outside the Newborn Period. Critical Care Clinics. 21(4). S9–S17. 66 indexed citations

16.

Singh, Rani H., William J. Rhead, Wendy E. Smith, et al.. (2005). Nutritional Management of Urea Cycle Disorders. Critical Care Clinics. 21(4). S27–S35. 30 indexed citations

17.

King, Lisa Sniderman, Rani H. Singh, William J. Rhead, et al.. (2005). Genetic Counseling Issues in Urea Cycle Disorders. Critical Care Clinics. 21(4). S37–S44. 17 indexed citations

18.

Smith, Wendy E., Stephen G. Kahler, Donald P. Frush, et al.. (2001). Hepatic storage of glycogen in Niemann-Pick disease type B. The Journal of Pediatrics. 138(6). 946–948. 2 indexed citations

19.

Amalfitano, Andrea, A. Resai Bengur, Richard P. Morse, et al.. (2001). Recombinant human acid α-glucosidase enzyme therapy for infantile glycogen storage disease type II: Results of a phase I/II clinical trial. Genetics in Medicine. 3(2). 132–138. 293 indexed citations

20.

Smith, Wendy E.. (1995). Child Care in the 21st Century: Why Educators Should Consider Implementing It in Their Schools.. Educational Technology archive. 35(2). 47–52. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact